-
Je něco špatně v tomto záznamu ?
Development of humanized culture medium with plant-derived serum replacement for human pluripotent stem cells
M. Kunova, K. Matulka, L. Eiselleova, P. Trckova, A. Hampl, P. Dvorak
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- apoptóza účinky léků MeSH
- buněčná diferenciace účinky léků MeSH
- buněčné kultury metody MeSH
- buněčný cyklus účinky léků MeSH
- embryonální kmenové buňky cytologie MeSH
- fibroblasty účinky léků MeSH
- fixní kombinace léků MeSH
- indukované pluripotentní kmenové buňky MeSH
- kolagen MeSH
- kultivační média bez séra farmakologie MeSH
- kultivační média speciální farmakologie MeSH
- kultivační média MeSH
- laminin MeSH
- lidé MeSH
- pluripotentní kmenové buňky cytologie MeSH
- proliferace buněk účinky léků MeSH
- proteoglykany MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
For human embryonic stem cells (ESC) to be used in cell replacement therapies, they must be grown under good manufacturing conditions in a chemically defined medium that lacks animal proteins. This study examined the ability of a newly designed medium containing the plant-derived serum replacement VegetaCell and other reagents of human origin to support undifferentiated growth and pluripotency of human ESC. This medium was tested in several culture systems, using human fibroblasts as a feeder layer or Matrigel in a feeder-free culture. Even under the most stringent feeder-free conditions without conditioned medium, human ESC exhibited an undifferentiated morphology, expressed markers of undifferentiated cells, demonstrated high alkaline phosphatase activity and multilineage differentiation and retained a normal karyotype. Compared with human ESC grown in standard culture conditions, human ESC maintained in humanized VegetaCell medium show longer cell cycles and decreased cell death. The availability of an animal protein-free medium supplemented with the low-cost VegetaCell reagent expands the repertoire of media for culturing human ESC as well as induced pluripotent stem cells for drug testing and cell replacement therapy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12026762
- 003
- CZ-PrNML
- 005
- 20160322110606.0
- 007
- ta
- 008
- 120816s2010 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.rbmo.2010.06.027 $2 doi
- 035 __
- $a (PubMed)20884295
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kunova, Michaela $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 245 10
- $a Development of humanized culture medium with plant-derived serum replacement for human pluripotent stem cells / $c M. Kunova, K. Matulka, L. Eiselleova, P. Trckova, A. Hampl, P. Dvorak
- 520 9_
- $a For human embryonic stem cells (ESC) to be used in cell replacement therapies, they must be grown under good manufacturing conditions in a chemically defined medium that lacks animal proteins. This study examined the ability of a newly designed medium containing the plant-derived serum replacement VegetaCell and other reagents of human origin to support undifferentiated growth and pluripotency of human ESC. This medium was tested in several culture systems, using human fibroblasts as a feeder layer or Matrigel in a feeder-free culture. Even under the most stringent feeder-free conditions without conditioned medium, human ESC exhibited an undifferentiated morphology, expressed markers of undifferentiated cells, demonstrated high alkaline phosphatase activity and multilineage differentiation and retained a normal karyotype. Compared with human ESC grown in standard culture conditions, human ESC maintained in humanized VegetaCell medium show longer cell cycles and decreased cell death. The availability of an animal protein-free medium supplemented with the low-cost VegetaCell reagent expands the repertoire of media for culturing human ESC as well as induced pluripotent stem cells for drug testing and cell replacement therapy.
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a buněčné kultury $x metody $7 D018929
- 650 _2
- $a buněčný cyklus $x účinky léků $7 D002453
- 650 _2
- $a buněčná diferenciace $x účinky léků $7 D002454
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a kolagen $7 D003094
- 650 _2
- $a kultivační média $7 D003470
- 650 _2
- $a kultivační média speciální $x farmakologie $7 D017077
- 650 _2
- $a kultivační média bez séra $x farmakologie $7 D016895
- 650 _2
- $a fixní kombinace léků $7 D004338
- 650 _2
- $a embryonální kmenové buňky $x cytologie $7 D053595
- 650 _2
- $a fibroblasty $x účinky léků $7 D005347
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a indukované pluripotentní kmenové buňky $7 D057026
- 650 _2
- $a laminin $7 D007797
- 650 _2
- $a pluripotentní kmenové buňky $x cytologie $7 D039904
- 650 _2
- $a proteoglykany $7 D011509
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Matulka, Kamil $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Eiselleová, Lívia $7 _AN059522 $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Trckova, Petra $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Hampl, Aleš, $d 1962- $7 ola2002153626 $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Dvořák, Petr, $d 1956- $7 ola2002153627 $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00007348 $t Reproductive biomedicine online $x 1472-6491 $g Roč. 21, č. 5 (2010), s. 676-686
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20884295 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20160322110634 $b ABA008
- 999 __
- $a ok $b bmc $g 948804 $s 784108
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 21 $c 5 $d 676-686 $e 20100625 $i 1472-6491 $m Reproductive biomedicine online $n Reprod Biomed Online $x MED00007348
- LZP __
- $b NLK122 $a Pubmed-20120816/11/01